Enveric Biosciences, Inc. Common Stock
ENVBEnveric Biosciences, Inc. (ENVB) is a biotechnology company focused on developing innovative medicines derived from psychedelic and plant-based compounds. The company aims to create therapies for mental health and neurological conditions by utilizing psychedelic science and advanced drug development techniques.
Company News
Multiple health care stocks experienced significant price movements during Monday's after-market trading session, with some companies seeing notable gains while others experienced declines.
The latest trading day saw Enveric Biosciences, Inc. (ENVB) settling at $0.93, representing a -0.46% change from its previous close.
Enveric Biosciences, Inc. (ENVB) closed the most recent trading day at $0.90, moving -0.56% from the previous trading session.
BYRN, YMAB, SAND, CORT and ENVB have been added to the Zacks Rank #1 (Strong Buy) List on April 17, 2023.
Enveric Biosciences (ENVB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
